Dulaglutide Prevents Some Adverse Cardiovascular Outcomes in Patients with Diabetes
Abstract
Glucagon-like peptide-1 (GLP-1) agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors prevent some adverse cardiovascular (CV) events...
Paper Details
Title
Dulaglutide Prevents Some Adverse Cardiovascular Outcomes in Patients with Diabetes
Published Date
Jul 11, 2019
Journal
Volume
2019
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History